Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | TACR1 | P25103 | 2/20 | 0.42 |
| ▸ | MC4R | P32245 | 2/20 | 0.40 |
| ▸ | MC3R | P41968 | 1/20 | 0.40 |
| ▸ | CCKBR | P32239 | 8/20 | 0.39 |
| ▸ | FPR2 | P25090 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | UGCG | Q16739 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29823478 | 1.00 | PKM (0.45) | PKMTACR1MC4RMC3RCCKBR | |
| SCHEMBL1879075 | 0.78 | CCR1 (0.42) | — | |
| SCHEMBL29823437 | 0.78 | CCR1 (0.42) | — | |
| SCHEMBL28438648 | 0.78 | CCR1 (0.42) | — | |
| SCHEMBL1870607 | 0.76 | CCR3 (0.45) | — | |
| SCHEMBL29823495 | 0.76 | CCR3 (0.45) | — | |
| SCHEMBL5790256 | 0.73 | KMT2A (0.41) | — | |
| SCHEMBL29823683 | 0.72 | CCR3 (0.40) | — | |
| SCHEMBL1886461 | 0.72 | CCR3 (0.40) | — | |
| SCHEMBL1873995 | 0.70 | KMT2A (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115997009-A | Methods and compositions for in vivo transduction of hematopoietic stem and progenitor cells | 美真达治疗公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-111683669-A | Compositions and methods for hematopoietic stem and progenitor cell transplantation therapy | 美真达治疗公司 | 2020-09-18 | — | — | CN | disclosed |
| CN-111542597-A | Compositions and methods for expanding hematopoietic stem and progenitor cells | 美真达治疗公司 | 2020-08-14 | — | — | CN | disclosed |